G0525 – Management of established patient-caregiver dyad with dementia, moderate complexity, for use in cmmi model

Long description

Management of established patient-caregiver dyad with dementia, moderate complexity, for use in cmmi model

Short description

Est pt-cg dyad dem mod cmplx

Pricing indicator

13 Priced by the Medicare contractor (carrier)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

July 1, 2024

Last change

July 1, 2024 – No change

Nearby G codes

• G0517 – Removal of non-biodegradable drug delivery implants, 4 or more (services for subdermal implants)
• G0518 – Removal with reinsertion, non-biodegradable drug delivery implants, 4 or more (services for subdermal implants)
• G0519 – Management of new patient-caregiver dyad with dementia, low complexity, for use in cmmi model
• G0520 – Management of new patient-caregiver dyad with dementia, moderate complexity, for use in cmmi model
• G0521 – Management of new patient-caregiver dyad with dementia, high complexity, for use in cmmi model
• G0522 – Management of a new patient with dementia, low complexity, for use in cmmi model
• G0523 – Management of a new patient with dementia, moderate to high complexity, for use in cmmi model
• G0524 – Management of established patient-caregiver dyad with dementia, low complexity, for use in cmmi model
• G0526 – Management of established patient-caregiver dyad with dementia, high complexity, for use in cmmi model
• G0527 – Management of established patient with dementia, low complexity, for use in cmmi model
• G0528 – Management of established patient with dementia, moderate to high complexity, for use in cmmi model
• G0529 – In-home respite care, 4-hour unit, for use in cmmi model
• G0530 – Adult day center, 8-hour unit, for use in cmmi model
• G0531 – Facility-based respite, 24-hour unit, for use in cmmi model
• G0532 – Take-home supply of nasal nalmefene hydrochloride; one carton of two, 2.7 mg per 0.1 ml nasal sprays (provision of the services by a medicare-enrolled opioid treatment program);( list separately in addition to each primary code)
• G0533 – Medication assisted treatment, buprenorphine (injectable) administered on a weekly basis; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)